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Abstract 
Review on t(11;14)(q11;q32), with data on clinics, 
and the genes involved. 
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Clinics and pathology 
Disease 
B-cell lymphoid malignancies and multiple 
myeloma. 
Etiology 
B-cell lymphoid malignancies in 5: 3 chronic 
lymphocytic leukemia (CLL) (Schroder et al., 1981; 
Weisenburger et al., 1987; Bird et al., 1989), 1 
plasma cell leukemia (PCL) (Ueshima et al., 1983), 
1 mantle cell lymphoma (MCL) (Espinet et al., 
1999) and 2 multiple myeloma (MM) patients 
(Sawyer et al., 1995; Gozzetti et al., 2011). 
Epidemiology 
2 males and 5 females aged 45 to 78 years, median 
63 years. 
Prognosis 
Chromosome 14q32 translocations that are part of 
complex karyotypes are associated with an adverse 
prognosis in B-cell malignancies. 
Cytogenetics 
Note 
The breakpoint on chromosome 11 is 11q13 in the 
most common t(11;14)(q13;32), therefore some of 
the translocations described as t(11;14)(q11;q32) in 
early reports may involve 11q13 breakpoint. 
Additional anomalies 
Found in association with highly complex 
karyotypes, thus it is unclear if t(11;14)(q11;q32) 
was a primary aberration in these patients or it 
appeared as a secondary change during karyotypic 
progression. 
Genes involved and 
proteins 




IGH translocations relocate genes near active 
regulatory sequences of the partner gene, resulting 
in their overexpression. 




Translocations involving chromosome 14 at band 
q32, at the site of the immunoglobulin heavy chain 
(IGH) locus have been described in a spectrum of 
B-cell malignancies. In these translocations, various 
partner chromosomes have been described, 
including chromosome 11, of which the 
t(11;14)(q13;q32) that leads to the overexpression 
of the CCND1 gene is the most common. 
Chromosome translocations involving centromeric 
11q breakpoints are less frequent and have been 
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described only in sporadic cases of B-cell lymphoid 
malignancies and multiple myeloma. Although the 
mechanism of neoplastic transformation remains 
unknown, deregulation of the translocated partner 
gene as a consequence of its transposition into the 
IGH locus may represent a mechanism of oncogene 
activation. 
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